The UK is in the midst of a wide-ranging national industrial strategy which will influence the country’s future role in the global economy. The latest proposals look at the life sciences and healthcare sectors, perhaps the areas of this grand plan which will affect most people, including through the successful development – or otherwise – […]
GPs are comparatively less likely to intervene and offer stop-smoking support to cancer patients, than they are to people diagnosed with coronary heart disease. Lung cancer survivors who quit smoking within a year of diagnosis will live for longer than those who continue to smoke, according to new research led by the Universities of Oxford […]
A new study from Oxford reveals the health service costs for hospital care of people who self-harm, emphasising the need for effective clinical services and prevention initiatives. Self-harm by intentional poisoning or self-injury is a very common reason for presentation to hospital, especially in young people. It is often repeated and carries a significant risk […]
An innovative new sensor could improve how hospital staff monitor patient breath rates and stability, according to new Oxford University research. It is commonly understood that in both healthy animals and humans, arterial blood oxygen levels stay constant as we breathe. However, until now, the technology available has not been fast enough, or small enough, […]
University of Oxford researchers have been awarded £1.24 million to lead a medical diagnostics co-operative that will drive forward the development, evaluation and uptake of new medical diagnostic technologies to improve outcomes for patients in the community. For the full story on Oxford Diagnostic Evidence Co-operative website
A new tool developed by Oxford University researchers has been launched to identify which GP practices are prescribing ineffective and wasteful treatments. The tool is found on the OpenPrescribing.net, the first website of its kind to enable health professionals, patients and the public to easily explore patterns of prescribing nationally, in CCGs and by individual GP […]
The world’s first widespread human testing of a flu vaccine which NIHR Oxford BRC researchers hope will protect more over 65-year-olds against influenza has begun in the NHS. More than 10,000 people aged 65 and over will be asked to take part in a study supported by the National Institute for Health Research (NIHR) and […]
A new conjugate vaccine against typhoid has been proven in trials in Oxford to be safe and effective in preventing the disease, and can be used to protect both adults and children. A study published in The Lancet is the first clinical trial to show that immunisation with a new vaccine called Vi-TT is safe, well tolerated and […]
An international group of haematology scientists, including leading researchers in Oxford, have secured approval from the US Food and drug Administration (FDA) for a new leukaemia drug that has produced exciting results in clinical trials. The development of Enasidenib has given hope to people with a form of acute myeloid leukaemia (AML), one of the […]
A new screening test, funded by NIHR Oxford BRC, is being hailed the most efficient way to indicate risk of colorectal cancer. First stage UK research, published today, shows that an advanced computer algorithm technology can successfully indicate levels of risk by analysing previous blood test results in patients’ existing medical records. For the full […]